Sunhawk Vision Biotech, Inc. (TPEX:7759)

Sunhawk Vision Biotech Statistics

Total Valuation

TPEX:7759 has a market cap or net worth of TWD 2.65 billion. The enterprise value is 2.26 billion.

Market Cap	2.65B
Enterprise Value	2.26B

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:7759 has 70.07 million shares outstanding. The number of shares has increased by 11.22% in one year.

Current Share Class	70.07M
Shares Outstanding	70.07M
Shares Change (YoY)	+11.22%
Shares Change (QoQ)	+10.67%
Owned by Insiders (%)	22.80%
Owned by Institutions (%)	1.61%
Float	27.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	5.62
P/TBV Ratio	6.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-13.09
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-15.53

Financial Position

The company has a current ratio of 16.48, with a Debt / Equity ratio of 0.01.

Current Ratio	16.48
Quick Ratio	16.15
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-979.70

Financial Efficiency

Return on equity (ROE) is -44.89% and return on invested capital (ROIC) is -28.00%.

Return on Equity (ROE)	-44.89%
Return on Assets (ROA)	-27.14%
Return on Invested Capital (ROIC)	-28.00%
Return on Capital Employed (ROCE)	-37.05%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.65% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-59.65%
50-Day Moving Average	42.76
200-Day Moving Average	63.49
Relative Strength Index (RSI)	44.23
Average Volume (20 Days)	23,501

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-175.37M
Pretax Income	-172.39M
Net Income	-172.39M
EBITDA	-173.87M
EBIT	-175.37M
Earnings Per Share (EPS)	-2.47

Balance Sheet

The company has 401.02 million in cash and 5.55 million in debt, with a net cash position of 395.47 million or 5.64 per share.

Cash & Cash Equivalents	401.02M
Total Debt	5.55M
Net Cash	395.47M
Net Cash Per Share	5.64
Equity (Book Value)	471.80M
Book Value Per Share	6.73
Working Capital	393.58M

Cash Flow

In the last 12 months, operating cash flow was -144.89 million and capital expenditures -415,000, giving a free cash flow of -145.31 million.

Operating Cash Flow	-144.89M
Capital Expenditures	-415,000
Depreciation & Amortization	5.75M
Net Borrowing	-4.26M
Free Cash Flow	-145.31M
FCF Per Share	-2.07

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:7759 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.22%
Shareholder Yield	-11.22%
Earnings Yield	-6.50%
FCF Yield	-5.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1